Transient Expression of Genes Delivered to Newborn Rat Liver Using Recombinant AAV2/8 Vectors

被引：0

作者：

Flageul, Maude ^{[1
]}

Aubert, Dominique ^{[1
]}

Pichard, Virginie ^{[1
]}

Nguyen, Tuan Huy ^{[1
]}

Ferry, Nicolas ^{[1
]}

机构：

[1] CHU Hotel Dieu, Lab Biotherapies Hepat, INSERM, U948,EA 4274, F-44035 Nantes 1, France

来源：

HUMAN GENE THERAPY | 2009年 / 20卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：676 / 677

页数：2

共 50 条

[31] Impact of Age at Administration, Lysosomal Storage, and Transgene Regulatory Elements on AAV2/8-Mediated Rat Liver Transduction [J].

Cotugno, Gabriella ;

Annunziata, Patrizia ;

Barone, Maria Vittoria ;

Karali, Marianthi ;

Banfi, Sandro ;

Auricchio, Alberto .

PLOS ONE, 2012, 7 (03)

[32] AAV2/7 and AAV2/8 mediated liver directed gene therapy enables long-term expression of the human LDL receptor and substantially diminishes atherosclerosis in LDL receptor deficient mice [J].

Lebherz, C ;

Gao, GP ;

Louboutin, JP ;

Millar, J ;

Rader, D ;

Wilson, JM .

CIRCULATION, 2003, 108 (17) :143-143

[33] Liver directed gene therapy using AAV2/8 substantially diminishes atherosclerosis in LDL receptor deficient mice [J].

Lebherz, C ;

Gao, GP ;

Louboutin, JP ;

Millar, J ;

Wilson, JM ;

Rader, DJ .

MOLECULAR THERAPY, 2003, 7 (05) :S229-S229

[34] Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria [J].

Harding, CO ;

Gillingham, MB ;

Hamman, K ;

Clark, H ;

Goebel-Daghighi, E ;

Bird, A ;

Koeberl, DD .

GENE THERAPY, 2006, 13 (05) :457-462

[35] Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria [J].

C O Harding ;

M B Gillingham ;

K Hamman ;

H Clark ;

E Goebel-Daghighi ;

A Bird ;

D D Koeberl .

Gene Therapy, 2006, 13 :457-462

[36] Effect of human vitreous humour components and neutralising antibodies on transduction activity of recombinant AAV2, AAV5, AAV6 and AAV8 [J].

Andrzejewski, S. ;

Moyle, P. ;

Stringer, B. ;

Steel, J. ;

Layton, C. J. .

HUMAN GENE THERAPY, 2019, 30 (08) :A10-A11

[37] Transgene expression from recombinant AAV-8 vectors in the liver occurs independently of the serotype origin of the viral inverted terminal repeats [J].

Grimm, D ;

Nakai, H ;

Storm, TA ;

Riu, EP ;

Kay, MA .

MOLECULAR THERAPY, 2004, 9 :S38-S38

[38] Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses [J].

Kuate, S ;

Stefanou, D ;

Hoffmann, D ;

Wildner, O ;

Überla, K .

JOURNAL OF GENE MEDICINE, 2004, 6 (11) :1197-1205

[39] OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA [J].

Mietzsch, Mario ;

Hering, Henrik ;

Hammer, Eva-Maria ;

Agbandje-McKenna, Mavis ;

Zolotukhin, Sergei ;

Heilbronn, Regine .

HUMAN GENE THERAPY METHODS, 2017, 28 (01) :15-22

[40] Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors [J].

Tan, Mei Hong ;

Smith, Alexander J. ;

Pawlyk, Basil ;

Xu, Xiaoyun ;

Liu, Xiaoqing ;

Bainbridge, James B. ;

Basche, Mark ;

McIntosh, Jenny ;

Tran, Hoai Viet ;

Nathwani, Amit ;

Li, Tiansen ;

Ali, Robin R. .

HUMAN MOLECULAR GENETICS, 2009, 18 (12) :2099-2114

← 1 2 3 4 5 →